JMS CO., LTD.
http://www.jms.cc/
Company Code No. 7702

Financial Statements
for the Fiscal Year Ended March 31, 2014
(From Apr. 1, 2013 to Mar. 31, 2014)

Summary of consolidated results

The assessment figures described on this report are based on available information
at this moment, including uncertain data. Actual results may be different from the figures.

1

Highlights in Business Results
10th straight year of increased sales, but decreased profit for the Fiscal Year Ended March 31, 2014

Sales: JPY 53.8 billion, up 9.8%

( %: compared with previous year)

Sales[Japan]‐ Continued growth in the sales of enteral nutrition products and medical gloves‐ Increased sales of hemodialysis machines with new features[Overseas]‐Positive sales of apheresis kits for an OEM customer‐Influence of exchange conversion by the weak yen

Operating income: JPY 900 million, down 43.5%,
Ordinary income: JPY 1,187 million, down 36.8%, Net income: JPY 207 million, down 83.8%
Profit‐Due to the depreciation cost of automated equipments for production enhancement‐The increase of selling expenses such as commission and transportation fees
‐The increase of tax expense due to the reversal of deferred tax assets under tax effectaccounting

Dividend forecast for the Fiscal Year Ended Mar. 2014
‐Annual dividend: JPY 8 per share (incl. interim dividend JYP 4 per share)2Consolidated Business Results
10th straight year of increased sales, but decreased profit
Apr. ‐ Mar. 2013

Apr. ‐ Mar. 2014

ResultsResults(unit: JPY million)
Year‐over‐Year

Sales

49,06853,8609.8%

Operating Income

1,594900(43.5%)

Ordinary Income

1,879

1,187(36.8%)

Net Income

1,277207(83.8%)

JPY 29.41

JPY 4.25‐‐‐

Net Income per share

Exchange Rate (average during period)(unit: JPY)

US Dollar

83.10

100.24‐‐‐Euro

102.63129.68‐‐‐Singapore Dollar

66.88

79.62

‐‐‐
3

Sales by segment (geographical area)(unit: JPY million)

Apr. – Mar. 2013

Apr. – Mar. 2014

45,00040,00039,758

Sales incl. internal transaction

41,049

Sales for third party

35,00035,37336,84916,733
14,497

15,00010,000
5,000

6,770

8,276

3,186
1,006

0JapanSoutheast Asia

3,770

2,550

3,032

1,389 2,547

3,028

China

Germany

2,134

2,705

2,134

2,705

United States

1,236
1,236

1,611
1,611

Others4

Profit by segment (geographical area)(unit: JPY million)

Apr. – Mar. 2013

Apr. – Mar. 2014

1,600
1,418

1,200
939

800

331

400

188
660(400)

Japan(303)Southeast Asia

45

20

China

116

Germany115

United States

72

63

Others5

Summary by segment (geographical area)%: year‐over‐yearSales
Ordinary IncomeJapan

SoutheastAsia

3.2%

939 JPY mil.

(33.8%)‐Continued growth in the sales of enteralnutrition products and medical gloves as well as
hemodialysis machines with new features
brought net sales

Oral/Enteral Nutrition Systems

Sales

16,733 JPY mil.

15.4%

Ordinary Income(303) JPY mil.

－‐Positive sales of apheresis kits for an OEMcustomer as well as blood bags for Japan boosted
net sales

Oral/Enteral Nutrition Systems is designed for use
when providing nutrition treatment (which uses atube to send nutrients directly into the patient'sbody) to patients who have difficulty absorbing
nutrients through standard meals.

Hemodialysis Machines
Sales
Ordinary Income

China

41,049 JPY mil.

3,770 JPY mil.

18.3%

20 JPY mil.

(55.9%)‐Continued growth in the sales of AV fistula needles
for Western and the domestic markets raised netsales

Hemodialysis machine is a
device for pulling blood from apatient into an extracorporeal
circuit. The blood is purified bya dialyzer and returned to thepatient by the hemodialysis
machine.
6

Summary by segment (geographical area)%: year‐over‐year

Sales
Ordinary Income
Germany

3,032 JPY mil.

18.9%

331 JPY mil.

183.8%‐Despite the sales drop of AV fistula needles forthe domestic markets, strong sales of dialysis
therapy chairs for the Middle and Near East raisednet sales

Sales
Ordinary Income

2,705 JPY mil.

26.7%

188 JPY mil.

63.9%

Blood bags
Blood bag is used for collection, storage andtransfusion of blood.

‐Positive sales of blood bags for the South andCentral America as well as AV fistula needles forUnited States the domestic markets boosted net sales

Sales
Ordinary Income
Others1,611 JPY mil.

30.3%

63 JPY mil.

(12.1%)AV Fistula Needle
AV fistula needle is for pulling blood from apatient during a dialysis therapy.
7

Sales by Business Segment(unit: JPY million)

Apr. – Mar. 2013

Apr. – Mar. 2014

30,00025,00020,00025,48815,00022,87017,39015,793

10,000
5,000
4,337
0

Infusion andTransfusion

Dialysis

4,658

General Medical
Supplies

4,395

4,523
1,671

Cardiovascular

1,799

Others
8Sales by Segment (Customer's Location)(unit: JPY million)

Apr. – Mar. 2013

40,00034,92936,519Others 3%

Asia・Oceania 12%

30,000

Apr. – Mar. 2014

Europe 8%

Apr. – Mar.
2014
20,000
North America 9%Japan 68%

10,000
3,731

4,766

3,626

4,334

5,188

6,634
1,5910Japan

North AmericaEurope

Asia・Oceania

1,605

Others9Selling, General and Admin. Expenses(unit: JPY million)

15,000(unit: JPY million)

12,721

12,0009,000

11,844

24.1%

23.6%

20%

10%

3,000

0

Apr. ‐ Mar.
2014

Labor Cost

5,275

5,545

270

5.1%

Transport

1,401

1,614

213

15.2%

R&D

1,243

1,228(15)(1.2%)

345

409

63

18.4%

3,578

3,924

345

9.7%

11,844

12,721877

7.4%

Depreciation

6,000

Apr. – Mar. Apr. – Mar.
2013
2014

Year‐over‐Year

Apr. ‐ Mar.
2013

30%

Others
Total

Diff.

0%

10Ordinary Income: Compared with the previous year
Minus factor
OrdinaryIncome
Apr.‐Mar. 2013

Plus factor

1,879
（193）

Ordinary income decreased
JPY 691 million

OrdinaryIncome
Apr.‐Mar. 2014

(unit: JPY million)

Decrease ofGross Profit（463）

Increase of SGA（13）

Decrease of
Non‐operating profit(20)

Impact of
Exchange rate

1,187
The underlined figures exclude impact of exchange rate.
11Forecast for FYE Mar. 2015
(unit: JPY million)FYE Mar. 2014
ResultSalesFYE Mar. 2015
ForecastYear‐over‐Year

53,86056,000

4.0%

Operating Income

900

1,200

33.2%

Ordinary Income

1,187

1,400

17.9%

207

800

285.7%

JPY 4.25

JPY 16.41‐‐‐

Net Profit
Net profit per hare
Exchange Rate (average during period)(unit: JPY)

US Dollar

100.24100.00Euro129.68134.00Singapore Dollar

79.62

81.00

‐‐‐‐‐‐‐‐‐
12Topics< Oct. – 2013 >‐ Date shows the press release date in Japan.

‐Business alliance in the field of hemodiafiltration
with Asahi Kasei Medical Co., Ltd.
April 7, 2014
The blood bag for blood donation‐Patent and Know‐How License Agreement with Huaren Pharmaceutical Co., Ltd. ,regarding medical devices and pharmaceutical drugs for Peritoneal Dialysis
Dec. 10, 2013
‐Supply of blood bag to the Japanese Red Cross Society
Oct. 25, 2013
‐Launching new product
Surgeon’s Gloves, “GAMMEX Powder‐free AF (Accelerator‐Free) Micro”
Oct. 04, 2013
Surgeon’s Gloves「GAMMEX Powder-free AF (Accelerator-Free) Micro」
13

The Bridge to Good Health CareJMS will continue its activities for contributing to medicalcare, with our corporate philosophy “Patient comes first”.
JMS continue to dedicate effort to creating happiness forpatients, their families and medical staff in line with its basic
principle, “delivering goods and services for our customer’ssatisfaction ”.
Thank you very much for your patronage and support.

14